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Abstract 
The proof of concept of a continuously sensing affinity device based on the glucose-dependent viscosity of a sensitive solution 
containing dextran and Concanavalin A has been successfully demonstrated. The biosensor incorporates a piezoelectric 
diaphragm and a flow-resisting microchannel for viscosity detection, and a free-standing Anodic Alumina Oxide (AAO) porous 
nano-membrane as glucose selective interface. Extensive in vitro glucose measurements between two physiologically relevant 
glucose concentrations, 2 mM and 9 mM (respectively hypo- and hyperglycemia), were successfully performed during 4 days. To 
the best of our knowledge, such reversibility and stability of glucose measurement over time had not been reported yet. 
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1. Introduction 
Diabetes mellitus is a metabolic disease resulting in abnormally high blood glucose levels. Serious long-term 
complications including cardiovascular disease, chronic renal failure and retinal damage are caused by chronic high 
glucose levels. Continuous glucose monitoring would allow a better diabetes management compared to current 
finger pricking, and would therefore reduce the risk of complications. 
Existing minimally invasive systems are mostly based on electrochemical detection of enzyme-catalyzed 
reactions1. Electrochemical methods are sensitive but have several drawbacks when working in the subcutaneous 
tissue. The signal generated by the enzyme electrode depends on the glucose diffusion and therefore biofouling 
affects the device sensitivity. Furthermore, the presence of other electrochemically active solutes often produces 
inaccuracies. As a result, electrochemical sensors exhibit large drifts and require individual and frequent calibrations 
on the basis of parallel capillary blood analysis1. 
Alternative sensing methods, using competitive affinity binding of glucose, have shown great promise in 
overcoming these limitations2-4. Such methods are typically based on a solution of a polysaccharide cross-linked by 
a glucose-binding protein2. When glucose is added to the solution, it binds competitively to the glucose-binding 
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 protein, which can be detected via the resulting changes in solution properties, such as fluorescence or viscosity. 
Affinity sensing is more tolerant to biofouling, which results only in an increased stabilization time. Furthermore, 
affinity sensing does not degrade any glucose and is therefore not susceptible to electroactive interferents. 
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Fig. 1. Schematic view of the glucose biosensor.  
2. Sensing principle 
The affinity sensing solution is based on a protein, Concanavalin A (ConA), which specifically binds to glucose, 
and a branched polysaccharide, a high-molecular-weight dextran. At low glucose concentration, dextran molecules 
are crosslinked by binding to ConA, forming a viscous solution. When the glucose concentration increases, dextran 
is partially replaced by glucose at the binding sites of ConA. As a result, the network ConA-dextran is weakened, 
and the viscosity of the sensing solution decreases. This competitive affinity assay is reversible and highly sensitive. 
The change in viscosity can be one order of magnitude in the physiologically relevant glucose range (1-30 mM)3.  
The viscosity detection of the sensitive solution is based on a microchannel which exhibits a resistance to the 
flow circulating through. The viscometric glucose sensor, which is intended to be implanted subcutaneously, is 
illustrated in Fig. 1. The biosensor comprises two chambers (actuating and sensing chambers) containing the glucose 
sensitive solution, which communicate through the microchannel. The biosensor is hermetically sealed by a free 
standing AAO porous nano-membrane confining the dextran and ConA molecules, and letting the glucose contained 
in the interstitial fluid permeating through. The bottom of the two chambers consists of piezoelectric diaphragms 
which bend when applying a voltage or produce a voltage when deformed. 
When applying a voltage, the actuating piezoelectric diaphragm bends, which generates a flow through the 
microchannel. As a result a deflection of the sensing piezoelectric diaphragm occurs, inducing a voltage which can 
be recorded. Due to its section, the microchannel exhibits a resistance to the flow which depends upon the viscosity 
of the sensitive solution. The delay between the excitation (burst or harmonic) and the deflection depends on the 
viscosity of the fluid. Such a biosensor may be fabricated using MEMS technology, bringing advantages such as 
miniaturization and reproducibility. 
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Fig. 2. Experimental in vitro setup. 
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3. Experimental setup 
A macroscopic proof of concept of the biosensor has been realized. The demonstrator incorporates a 100 μm in 
diameter cylindrical microchannel and a 6.5 mm in diameter piezoelectric diaphragm for viscosity detection. The 
sensitive solution is confined in the biosensor using a 5-7 nm AAO porous nano-membrane as glucose selective 
interface (Synkera Technologies, Inc.). The biosensor has a volume of 80 μl and the surface of the selective interface 
is 12 mm2. The displacement of the piezoelectric diaphragm is recorded using a specular-reflective laser 
displacement meter (LC-2420 from Keyence). 
The experimental in vitro setup is represented in Fig. 2. The interstitial fluid is mimicked by a reference which is 
an isotonic solution of the sensitive fluid, but without dextran and ConA.  A peristaltic pump makes the reference 
solution circulating in order to maintain a constant glucose concentration outside the biosensor. The glucose 
concentration is increased by injecting small amounts of concentrated (2M) D-glucose solution with a microliter 
syringe. The reference solution is flushed and replaced when a decrease in glucose concentration is desired. The 
whole setup is located in a thermally regulated chamber, as the viscosity of the sensitive fluid is strongly 
temperature dependant. 
4. Results and discussion 
The deflection of the piezoelectric diaphragm was characterized when applying a slowly varying sinusoidal 
voltage. With a voltage of 25 V, the center of the piezoelectric diaphragm was deflected of 4.3 μm. Such a 
deflection displaces a volume of 0.04 μl, which corresponds to a fluid displacement of 5.2 mm in the microchannel, 
enabling sensitive viscosity detection as well as efficient mixing between the two chambers. The demonstrator was 
then characterized using 5 viscosity reference standards (Paragon Scientific Ltd), exhibiting dynamic viscosities 
ranging from 3.65 mPa s to 17.25 mPa s at 20°C. 20 measurements were recorded for each viscosity, showing a 
good accuracy (mean standard deviation of 0.18%) and stability. 
A long-term measurement was performed during 4 days at 25°C, between two physiologically relevant glucose 
concentrations, 2 mM and 9 mM (Fig. 3). A sinusoidal voltage with a frequency of 0.5 Hz and an amplitude of 25 V 
was applied to the piezoelectric diaphragm. The measured phase shift was stable and reversible throughout the 
experiment. The reversibility of the sensitive solution had already been shown by Ballerstädt et al. for one cycle of 
glucose change during a short period2. But the sensitive solution confined by a semi-permeable membrane was not 
stable, thus hindering from getting long-term reversible results. Due to its small hydrodynamic radius (3.3 nm in 
dimer configuration), ConA leakage was though to be responsible of the sensitive solution instability. The 5-7 nm 
AAO porous nano-membrane completely confines dextran and ConA molecules inside the demonstrator, resulting in 
a long-term stability of measurements. 
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Fig. 3. In vitro glucose concentration measurement at 25°C, between two physiologically relevant glucose concentrations, 2 mM and 9 mM, 
showing excellent stability and reversibility over 4 days. 
C. Boss et al. / Procedia Chemistry 1 (2009) 313–316 315
 30
35
40
45
0 2 4 6 8
Time [hour]
Ph
as
e 
sh
ift
 [d
eg
]
2 mM
12 mM
2 mM
 
Fig. 4. In vitro glucose concentration measurement at 37°C, between two physiologically relevant glucose concentrations, 2 mM and 12 mM. 
Arrows indicate changes of glucose concentration in the reference solution. 
Glucose measurements were then performed at 37°C, to evaluate the response time of the demonstrator at 
physiological temperature. A glucose concentration measurement between 2 mM and 12 mM is shown in Fig. 4. A 
sinusoidal voltage with a frequency of 2 Hz and an amplitude of 25 V was applied to the piezoelectric diaphragm. 
Curve fittings with a decreasing exponential were performed, which gave a time constant of 20.4 min when 
increasing the glucose concentration, and a time constant of 73.2 min when decreasing the glucose concentration. A 
longer time constant when decreasing the glucose concentration has also been observed for other similar 
experiments, and might be explained by the smaller mobility of glucose molecules in the viscous sensitive solution 
than in the reference solution. The response time of the demonstrator is very long, due to the large volume of 
sensitive solution and particularly to the small semi-permeable surface compared to the volume of the sensitive 
solution. Currently, a new demonstrator is being developed, which will address the long equilibration time issue 
through size reduction and semi-permeable surface increase. Time constants between 3-10 min are expected. 
5. Conclusion 
A proof of concept for a long-term implantable glucose sensor was demonstrated. Reversible and stable 
measurements, between two physiologically relevant glucose concentration, 2 mM and 9 mM, were successfully 
performed during 4 days. The viscometric sensitive solution confined by a nanoporous AAO membrane was shown 
to be stable and therefore suitable for long-term continuous glucose monitoring. Moreover, the viscosity 
measurement principle, based on two piezoelectric diaphragms, would be suitable for long-term implantation due to 
its low-power consumption. This demonstrator represents a first step towards long-term implantable glucose sensing 
using a non-consumptive viscometric affinity assay. Miniaturization of the device using MEMS technology, and 
biofouling and fibrous encapsulation following the subcutaneous implantation are the remaining critical hindrances, 
and will be the object of future studies. 
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